EP3523321A4 - Compositions et procédés d'expression et d'administration de protéines - Google Patents
Compositions et procédés d'expression et d'administration de protéines Download PDFInfo
- Publication number
- EP3523321A4 EP3523321A4 EP17858829.9A EP17858829A EP3523321A4 EP 3523321 A4 EP3523321 A4 EP 3523321A4 EP 17858829 A EP17858829 A EP 17858829A EP 3523321 A4 EP3523321 A4 EP 3523321A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- delivery
- compositions
- methods
- protein expression
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 title 1
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/513—Organic macromolecular compounds; Dendrimers
- A61K9/5169—Proteins, e.g. albumin, gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Optics & Photonics (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physics & Mathematics (AREA)
- Nanotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662405613P | 2016-10-07 | 2016-10-07 | |
PCT/SG2017/050505 WO2018067075A1 (fr) | 2016-10-07 | 2017-10-06 | Compositions et procédés d'expression et d'administration de protéines |
Publications (2)
Publication Number | Publication Date |
---|---|
EP3523321A1 EP3523321A1 (fr) | 2019-08-14 |
EP3523321A4 true EP3523321A4 (fr) | 2020-07-08 |
Family
ID=61831159
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP17858829.9A Pending EP3523321A4 (fr) | 2016-10-07 | 2017-10-06 | Compositions et procédés d'expression et d'administration de protéines |
Country Status (8)
Country | Link |
---|---|
US (1) | US11510881B2 (fr) |
EP (1) | EP3523321A4 (fr) |
JP (1) | JP7096239B2 (fr) |
KR (1) | KR102579209B1 (fr) |
CN (1) | CN110023328B (fr) |
IL (1) | IL265831B1 (fr) |
SG (2) | SG10201911421VA (fr) |
WO (1) | WO2018067075A1 (fr) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2019092481A (ja) * | 2017-11-27 | 2019-06-20 | 国立大学法人東京工業大学 | ヘテロタンパク質ケージ |
JP2019193594A (ja) * | 2018-05-01 | 2019-11-07 | 国立大学法人東京工業大学 | 融合タンパク質及びその使用 |
KR20220057542A (ko) * | 2019-09-05 | 2022-05-09 | 아지노모토 가부시키가이샤 | 펩타이드 내포 페리틴 |
CN112094861B (zh) * | 2020-10-26 | 2022-11-22 | 南京林业大学 | 一种绿藻植物铁蛋白的表达纯化方法及其应用 |
WO2024043836A1 (fr) * | 2022-08-25 | 2024-02-29 | National University Of Singapore | Administration de protéine stabilisée par un tractus gastro-intestinal à l'aide d'un système de tes de disulfure |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7033613B2 (en) * | 2001-05-14 | 2006-04-25 | Matsushita Electric Industrial Co., Ltd. | Recombinant cage-like protein, method for producing the same, precious metal-recombinant cage-like protein complex, method for producing the same and recombinant DNA |
WO2016048246A1 (fr) * | 2014-09-25 | 2016-03-31 | Nanyang Technological University | Ciblage de mélanocytes pour une administration d'agents diagnostiques ou thérapeutiques au moyen de nanocages protéiques |
EP3250233A4 (fr) * | 2015-01-29 | 2018-07-25 | Agency for Science, Technology and Research | Nanocapsules contenant des peptides associés au chikungunya |
-
2017
- 2017-10-06 JP JP2019518924A patent/JP7096239B2/ja active Active
- 2017-10-06 WO PCT/SG2017/050505 patent/WO2018067075A1/fr unknown
- 2017-10-06 EP EP17858829.9A patent/EP3523321A4/fr active Pending
- 2017-10-06 IL IL265831A patent/IL265831B1/en unknown
- 2017-10-06 CN CN201780073646.4A patent/CN110023328B/zh active Active
- 2017-10-06 SG SG10201911421VA patent/SG10201911421VA/en unknown
- 2017-10-06 KR KR1020197012269A patent/KR102579209B1/ko active IP Right Grant
- 2017-10-06 SG SG11201902945SA patent/SG11201902945SA/en unknown
- 2017-10-06 US US16/340,089 patent/US11510881B2/en active Active
Non-Patent Citations (2)
Title |
---|
LUCAS: "UNIPROT:H9UBI8", 7 September 2016 (2016-09-07), XP055698930, Retrieved from the Internet <URL:https://www.uniprot.org/uniprot/H9UBI8.txt?version=26> [retrieved on 20200527] * |
WEI SUN ET AL: "Salt-Dependent Aggregation and Assembly of E coli -Expressed Ferritin", DOSE-RESPONSE, vol. 14, no. 1, 26 February 2016 (2016-02-26), US, XP055699458, ISSN: 1559-3258, DOI: 10.1177/1559325816632102 * |
Also Published As
Publication number | Publication date |
---|---|
IL265831A (en) | 2019-06-30 |
SG11201902945SA (en) | 2019-05-30 |
JP2019534700A (ja) | 2019-12-05 |
IL265831B1 (en) | 2024-09-01 |
CN110023328B (zh) | 2024-03-05 |
CN110023328A (zh) | 2019-07-16 |
WO2018067075A1 (fr) | 2018-04-12 |
US20210113484A1 (en) | 2021-04-22 |
EP3523321A1 (fr) | 2019-08-14 |
US11510881B2 (en) | 2022-11-29 |
KR102579209B1 (ko) | 2023-09-15 |
SG10201911421VA (en) | 2020-02-27 |
KR20190062483A (ko) | 2019-06-05 |
JP7096239B2 (ja) | 2022-07-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3694489A4 (fr) | Procédés et compositions à administration topique | |
IL262321A (en) | Preparations and methods for selective protein expression | |
EP3355954A4 (fr) | Méthodes et compositions d'administration | |
EP3596213A4 (fr) | Compositions et procédés d'amplification d'expression génique | |
EP3471778A4 (fr) | Compositions et méthodes pour administrer des agents biomacromoléculaires | |
EP3436482A4 (fr) | Anticorps, compositions pharmaceutiques et procédés | |
EP3585433A4 (fr) | Compositions thérapeutiques et méthodes associées pour la photoimmunothérapie | |
EP3273944A4 (fr) | Compositions et procédés permettant d'administrer des agents de type biomacromolécule | |
EP3300507A4 (fr) | Méthodes et compositions d'administration génique | |
EP3493827A4 (fr) | Compositions et procédés pour immunothérapie | |
EP3328377A4 (fr) | Compositions et méthodes pour thérapies immuno-oncologiques | |
EP3380125A4 (fr) | Conjugués comprenant des groupes peptidiques et procédés associés à ceux-ci | |
EP3373906A4 (fr) | Compositions et procédés destinés à une application sur la peau | |
EP3316909A4 (fr) | Anticorps anti-ntb-a ainsi que compositions et procédés associés | |
EP3268050A4 (fr) | Compositions de conjugués de protéines porogènes et procédés correspondants | |
EP3302532A4 (fr) | Compositions et procédés en rapport avec des agents biologiques antistaphylococciques | |
EP3474857A4 (fr) | Compositions et méthodes de libération d'agents thérapeutiques | |
EP3182985A4 (fr) | Composition protéique dérivée de fibroïne | |
EP3503879A4 (fr) | Compositions et procédés associés | |
EP3442543A4 (fr) | Compositions et méthodes pour la neurogenèse | |
EP3523321A4 (fr) | Compositions et procédés d'expression et d'administration de protéines | |
EP3488018A4 (fr) | Procédés et compositions pour l'identification de protéines | |
EP3253389A4 (fr) | Compositions d'apilimod et procédés d'utilisation correspondants | |
EP3642219A4 (fr) | Compositions peptidiques et procédés associés | |
EP3182970A4 (fr) | Compositions et procédés d'enrobages en cannabinoïdes utilisés dans l'administration de médicaments |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20190409 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20200608 |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A61K 9/51 20060101ALI20200602BHEP Ipc: C07K 14/47 20060101AFI20200602BHEP |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20231116 |